Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

@article{Sisk1997CosteffectivenessOV,
  title={Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.},
  author={Jane E. Sisk and Alan J. Moskowitz and William Whang and Jen-Der Lin and David S. Fedson and Alexander M. McBean and Joseph F Plouffe and Marty S Cetron and J. Corey Butler},
  journal={JAMA},
  year={1997},
  volume={278 16},
  pages={1333-9}
}
CONTEXT Clinical, epidemiologic, and policy considerations support updating the cost-effectiveness of pneumococcal vaccination for elderly people and targeting the evaluation only to prevention of pneumococcal bacteremia. OBJECTIVE To assess the implications for medical costs and health effects of vaccination against pneumococcal bacteremia in elderly people. DESIGN Cost-effectiveness analysis of pneumococcal vaccination compared with no vaccination, from a societal perspective. SETTING… CONTINUE READING